Subscribe To
Paypal gets a lift. why the stock could be too cheap to fail.
An earnings beat and new management are putting turnaround hopes front and center for the payments company....
November 2, 2023, 9:16 am
Gold price forecast – gold markets recover slightly on thursday
Gold markets rallied just a bit during the trading session on Thursday, as it looks like we continue to...
November 2, 2023, 9:15 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-...
November 2, 2023, 9:15 am
Ftse 100 rallies ahead of boe rate decision
U.K. stocks advanced on Thursday as investors reacted to...
November 2, 2023, 9:14 am
Best small business loans 2023
If the business doesn’t have sufficient cash reserves to fund their plans, a small business loan can bridge the gap. Indeed, the British Business Ba...
November 2, 2023, 9:14 am
stock market today: wall street rises after federal reserve holds steady on interest rates
stocks are rising after the Federal Reserve opted against...
November 2, 2023, 9:14 am
Gbp/jpy keeps the red around 183.00, defends 100-day sma support ahead of boe
GBP/JPY drifts lower for the second straight day, though the downside remains limited. Intervention fea...
November 2, 2023, 9:14 am
At&t, verizon, or t-mobile: which telecom stock should you buy after earnings?
The three wireless carriers are all growing free cash flow faster than expected. Verizon and AT&T have ...
November 2, 2023, 9:14 am
After a year colt seals the $1.8b purchase of lumen emea
Colt, a service provider for numerous retail brokers, financial firms, and crypto exchanges, announced today (Thursday) that it has acquired Lumen EME...
November 2, 2023, 9:14 am
Sidus space awarded multi-million-dollar contract for commercial lunar transportation
Sidus Space Inc (NASDAQ:SIDU) announced that it has been awarded a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract, with a $10 mil...
November 2, 2023, 9:13 am
Editas medicine to present clinical data from the ruby and edithal trials of edit-301 at the ash 2023 annual meeting and in a company-sponsored webinar
Company to host a webinar to discuss EDIT-301 clinical data on Monday, December 11, at 1:00 p.m. ET Dr....
November 2, 2023, 9:12 am
This stock has a 6.05% yield and sells for less than book
the recent Ford share price of $9.91 represents a price-to-book ratio of 0.9 and an annual dividend yield of 6.05%...
November 2, 2023, 9:10 am
Building a sustainable portfolio: 3 esg stocks to buy and hold
At first, the idea of environmental, social and governance or ESG ...
November 2, 2023, 9:10 am
Nasdaq 100, dow jones, s&p 500 news: starbucks earnings could set early tone
As Nasdaq Composite investors eye corporate earnings, including ...
November 2, 2023, 9:10 am
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 po...
November 2, 2023, 9:10 am
Invest in the future: buy & hold visa, mcdonald's and microsoft forever
The uncertainty surrounding interest rates and the mixed earnings have pressured inve...
November 2, 2023, 9:09 am
Ford reports lower us vehicle sales in october
Ford reported a 5.3% drop in total U.S. vehicle sales in October after the United Workers Union (UAW) st...
November 2, 2023, 9:09 am
Ferrari again raises guidance as customers opt for high-priced, personalized sports cars
Ferrari raised guidance after its third-quarter profit surged 46% year over year. Its customers continu...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOstON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOstON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am